Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. The company also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves to patients and home health agencies, the U.S. federal government, and private insurers. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
Strategic Expansion | Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business |
Financial Challenges | Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability |
Market Dynamics | Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs |
Analyst Perspectives | Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution |
Metrics to compare | ACH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | 14.3x | −0.5x | |
PEG Ratio | 0.00 | 0.59 | 0.00 | |
Price/Book | −0.4x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 0.6x | 3.3x | |
Upside (Analyst Target) | 67.4% | 7.4% | 45.8% | |
Fair Value Upside | Unlock | 25.1% | 6.4% | Unlock |